Elevated liver enzymes in Turner syndrome during a 5-year follow-up study

Authors: El-Mansoury, Mostafa1; Berntorp, Kerstin2; Bryman, Inger3; Hanson, Charles3; Innala, Eva4; Karlsson, Anders5; Landin-Wilhelmsen, Kerstin6

Source: Clinical Endocrinology, Volume 68, Number 3, March 2008 , pp. 485-490(6)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Summary Objectives 

To study the prevalence and incidence of elevated liver enzymes and their relationship with body weight, metabolic factors and other diseases in Turner syndrome (TS). Design 

Five-year follow-up. Patients 

Women with TS (n = 218, mean age 33 ± 13, range 16-71 years) from outpatient clinics at university hospitals in Sweden. Measurements 

Fasting blood samples for aspartate (AST) and alanine aminotransferase (ALT), bilirubin, alkaline phosphatase (ALP), γ-glutamyl transferase (GT), viral hepatitis serology and hepatic auto-antibodies, vitamin B12, blood glucose, lipids and hormones. Results 

Seventy-nine subjects (36%) had one or more liver enzyme levels higher than the reference level, the most prevalent being GT. Karyotype 45,X was present in 51% of all TS women and in 48% of those with elevated liver enzymes. Body weight, body mass index (BMI), total cholesterol, triglycerides, and apolipoproteins A and B at start were higher in TS women with elevated liver enzymes than in TS women with normal levels. At 5 years, AST, ALT and GT were increased and another 23% of patients had developed elevated liver enzymes, that is, 59% in total (36% + 23%), while in 6%, the elevated liver enzymes had been normalized and all 6% also had lowered cholesterol levels. Multivariate analysis showed that GT was correlated with total cholesterol; P = 0·0032 at start and P = 0·0005 at 5 years, independently of other factors. Liver biopsy in six TS women showed one cholangitis, one hepatitis C, two steatosis and two normal biopsies. Withdrawal of oestrogen substitution did not influence the liver enzymes. Conclusions 

Pathological liver enzymes were common in TS women, with a prevalence of 36% at 33 years of age, an annual incidence over 5 years of 3·4%. There was no relation to karyotype, alcohol, viral hepatitis, E2 or autoimmunity, but a connection with total serum cholesterol.

Document Type: Research article

DOI: 10.1111/j.1365-2265.2007.03166.x

Affiliations: 1: Department of Internal Medicine, Sahlgrenska University Hospital/Östra, Göteborg, Sweden; 2: Department of Endocrinology, Malmö University Hospital, Malmö, Sweden, 3: Reproductive Medicine, Sahlgrenska University Hospital/Sahlgrenska, Göteborg, Sweden, 4: Department of Gynaecology, Umeå University Hospital, Umeå, Sweden, 5: Section for Endocrinology, Uppsala Academic University Hospital, Uppsala, Sweden and 6: Section for Endocrinology, Sahlgrenska University Hospital/Sahlgrenska, Göteborg University, Göteborg, Sweden

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A